Halyard Health, Inc. (NYSE:HYH) Shares Sold by TIAA CREF Investment Management LLC

TIAA CREF Investment Management LLC cut its stake in Halyard Health, Inc. (NYSE:HYH) by 4.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 150,020 shares of the medical instruments supplier’s stock after selling 7,020 shares during the period. TIAA CREF Investment Management LLC owned about 0.32% of Halyard Health worth $5,714,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of HYH. CENTRAL TRUST Co boosted its position in Halyard Health by 1.0% in the first quarter. CENTRAL TRUST Co now owns 2,643 shares of the medical instruments supplier’s stock valued at $101,000 after buying an additional 25 shares during the period. Meadow Creek Investment Management LLC boosted its position in Halyard Health by 1.1% in the first quarter. Meadow Creek Investment Management LLC now owns 2,660 shares of the medical instruments supplier’s stock valued at $101,000 after buying an additional 28 shares during the period. Glen Harbor Capital Management LLC boosted its position in Halyard Health by 1.1% in the first quarter. Glen Harbor Capital Management LLC now owns 3,230 shares of the medical instruments supplier’s stock valued at $123,000 after buying an additional 34 shares during the period. State Treasurer State of Michigan boosted its position in Halyard Health by 0.5% in the first quarter. State Treasurer State of Michigan now owns 18,920 shares of the medical instruments supplier’s stock valued at $721,000 after buying an additional 100 shares during the period. Finally, Advantus Capital Management Inc boosted its position in Halyard Health by 3.0% in the first quarter. Advantus Capital Management Inc now owns 5,975 shares of the medical instruments supplier’s stock valued at $228,000 after buying an additional 175 shares during the period. Hedge funds and other institutional investors own 91.40% of the company’s stock.

Shares of Halyard Health, Inc. (NYSE HYH) opened at 39.42 on Tuesday. The company has a market cap of $1.84 billion, a PE ratio of 48.01 and a beta of 1.78. Halyard Health, Inc. has a 12 month low of $31.59 and a 12 month high of $41.84. The firm’s 50 day moving average is $37.60 and its 200 day moving average is $38.35.

Halyard Health (NYSE:HYH) last issued its earnings results on Tuesday, May 2nd. The medical instruments supplier reported $0.48 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.05. The firm had revenue of $395.60 million for the quarter, compared to analyst estimates of $391.56 million. Halyard Health had a net margin of 2.40% and a return on equity of 8.16%. The company’s quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter last year, the business posted $0.53 earnings per share. On average, equities analysts predict that Halyard Health, Inc. will post $1.85 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This piece was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at https://sportsperspectives.com/2017/07/18/halyard-health-inc-nysehyh-shares-sold-by-tiaa-cref-investment-management-llc.html.

Several research firms recently weighed in on HYH. Zacks Investment Research upgraded shares of Halyard Health from a “sell” rating to a “buy” rating and set a $44.00 price objective for the company in a research report on Wednesday, May 3rd. TheStreet cut shares of Halyard Health from a “b-” rating to a “c” rating in a research report on Wednesday, May 3rd. Finally, BidaskClub upgraded shares of Halyard Health from a “hold” rating to a “buy” rating in a research report on Wednesday, June 28th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Halyard Health has an average rating of “Hold” and an average price target of $40.50.

About Halyard Health

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply